Aptevo Therapeutics Inc. Prepaid Expense, Current
Aptevo Therapeutics Inc. (APVO) had Prepaid Expense, Current of $539.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense, Current $539.00K.
- 2026-03-31: Prepaid Expense, Current $608.00K.
- 2025-12-31: Prepaid Expense, Current $609.00K.
- 2025-09-30: Prepaid Expense, Current $1.51M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $539.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $608.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $609.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.59M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.35M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $925.00K 10-K · filed 2026-03-26 | $1.69M 10-K · filed 2025-02-14 |
| 2024-09-30 | $1.64M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $798.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.13M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.47M 10-K · filed 2025-02-14 | |
| 2023-09-30 | $1.37M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $910.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.57M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.57M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $1.38M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $655.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.43M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.82M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.39M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $936.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.56M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $2.23M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.49M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $641.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.34M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.08M 10-K · filed 2021-03-31 | $4.23M 10-K · filed 2020-03-25 |
| 2019-09-30 | $2.21M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.20M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.92M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $6.91M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $5.20M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.86M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.09M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.02M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |